LAKEWOOD, Colo., USA—October 21, 2016—Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced that Antoinette Gawin has been appointed Executive Vice President, Global Commercial and a key member of the Terumo BCT Executive Management Committee. In this role, Gawin is responsible for global sales, marketing, business development and all commercial operations, as well as establishing the Company’s go-forward strategy and the associated infrastructure required to expand its position in emerging markets.
Gawin brings a wealth of knowledge and experience in sales leadership, strategic marketing and business development with nearly 30 years working in Fortune 100 companies, directing diverse global teams and transforming organizations.
Gawin served in several leadership roles at Baxter Healthcare, overseeing global market access, strategy and commercial operations. During her tenure, she restructured and accelerated growth for the commercial organization within the $5-billion Medication Delivery business. She successfully architected a company-wide cultural transformation, increasing profits and employee satisfaction during the first year. Gawin also built an organization of health economists and market access experts to influence global reimbursement coverage and catalyze physician and patient advocacy.
For 22 years, Gawin served in senior positions at GE Healthcare Technologies, GE Industrial and Power Systems, GE Information Systems and GE Corporate. Responsible for several business units, she was most recognized for her ability to work cross-functionally and successfully lead and influence large matrixed and virtual teams to higher performance. Along with residing in Scotland and Switzerland, Gawin has an extensive global background. This includes leading such diverse teams as strategic marketing, business development, information systems and finance, positioning her to drive international growth for each subsidiary.
Gawin is a recognized key opinion leader in the U.S. healthcare industry and is a frequently sought-after keynote speaker on such crucial topics as the Affordable Care Act, healthcare economics, customer intimacy programs and the future of innovation in healthcare.
“The depth and breadth of Antoinette’s leadership and global healthcare expertise will be immensely beneficial not only to our company but also to our customers and our overall industry,” said David Perez, President and CEO, Terumo BCT. “Her commercial strategy, business development and health policy background will guide Terumo BCT in navigating our future in the evolving global healthcare marketplace, and her steadfast passion for the customer and the patient make her an ideal cultural fit for our organization.”
About Terumo BCT
Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction technologies. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.
Sherri Hughes-Smith, Terumo BCT Global Integrated Communications
Products available in select markets.